Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06853275 · ClinicalTrials.gov registry record · NA

The Influence of Movement Velocity Biofeedback on Muscle Activation and Self Perception in Older Adults With Sarcopenia

A NA study of Sarcopenia and Sarcopenia in Elderly, sponsored by Creighton University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06853275: Recruiting NA study of Sarcopenia and Sarcopenia in Elderly, sponsored by Creighton University.

NCT06853275 is a NA study of Sarcopenia and Sarcopenia in Elderly that is actively recruiting participants, run by Creighton University. The registered enrollment target is 60 participants, below the 79-participant average among 41 other Sarcopenia trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06853275, a NA study of Sarcopenia and Sarcopenia in Elderly, is actively recruiting participants, sponsored by Creighton University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The overall objective for this clinical trial is to provide evidence for internal and external cueing for physical therapists and other rehabilitation clinicians to optimize resistance training within rehabilitation for older adults. The main questions it aims to answer are: * What is the impact of external focus (providing velocity of movement for each repetition) compared to internal focus (i.e., no cues, control group) on physical percent velocity loss and neuromuscular activation in older adults with sarcopenia? * Does internal and external focus influence motivation and perceptual workload following resistance training in older adults with sarcopenia? Researchers will compare external focus to internal focus to see if external focus impacts percent velocity loss, motivation, and perceived workload. Participants will: * Visit the lab once per week for 3 weeks * Perform exercise testing using a leg press * Answer questionnaires regarding perceived workload and motivation before and after exercise

Primary Outcome

The linear position transducer is a spring-powered retractable apparatus that attaches to the leg press on one end and to the machine near the participant's hip joint. Velocity data from a linear position transducer will be collected following each repetition. Percent velocity loss (%VL) measures the reduction in the movement speed from the initial repetition to the final repetition. The %VL will quantify the level of fatigue and performance decline that occurs throughout the repetitions of leg

Interventions

  • BEHAVIORAL Experimental: External Focus
  • BEHAVIORAL Other: Internal Focus

Study Locations (1)

Nebraska

  • Creighton University - Omaha

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-08-01
Est. Completion 2027-12-31
Phase NA
Creighton University

98 total trials

What NCT06853275 shows while recruiting

NCT06853275 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 79-participant average among 41 other Sarcopenia trials with a reported enrollment target (24% lower).

The record links to 3 conditions, with Sarcopenia appearing as the primary indexed condition, and to 2 interventions - of which Experimental: External Focus is the first listed.

NCT06853275 reports a single indexed study location in Nebraska.

Frequently Asked Questions

What is clinical trial NCT06853275 about?

NCT06853275 is a clinical study titled "The Influence of Movement Velocity Biofeedback on Muscle Activation and Self Perception in Older Adults With Sarcopenia". The overall objective for this clinical trial is to provide evidence for internal and external cueing for physical therapists and other rehabilitation clinicians to optimize resistance training within rehabilitation for older adults. The main questions it aims to answer are: * What is the impact of...

What is the current status of trial NCT06853275?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-08-01. Estimated completion is 2027-12-31.

What conditions does trial NCT06853275 study?

This clinical trial studies the following conditions: Sarcopenia, Sarcopenia in Elderly, Age-associated Muscle Loss.

What interventions are being tested in trial NCT06853275?

The interventions under investigation include: Experimental: External Focus (BEHAVIORAL), Other: Internal Focus (BEHAVIORAL).

Who is sponsoring clinical trial NCT06853275?

This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06853275 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sarcopenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06853275's enrollment target sits among peer trials

60 21st of 41 higher than 20 of 41 other Sarcopenia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sarcopenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06853275, the US trial registry maintained by the National Library of Medicine. NCT06853275 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.